- Home
- LAC vs CRMD Comparison
LAC vs CRMD Comparison
Compare LAC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAC
- CRMD
- Stock Information
- Founded
- LAC 2023
- CRMD 2006
- Country
- LAC Canada
- CRMD United States
- Employees
- LAC N/A
- CRMD N/A
- Industry
- LAC Metal Mining
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- LAC Basic Materials
- CRMD Health Care
- Exchange
- LAC Nasdaq
- CRMD Nasdaq
- Market Cap
- LAC 709.7M
- CRMD 576.4M
- IPO Year
- LAC N/A
- CRMD 2010
- Fundamental
- Price
- LAC $3.10
- CRMD $8.21
- Analyst Decision
- LAC Hold
- CRMD Strong Buy
- Analyst Count
- LAC 9
- CRMD 5
- Target Price
- LAC $5.06
- CRMD $15.80
- AVG Volume (30 Days)
- LAC 4.9M
- CRMD 861.3K
- Earning Date
- LAC 11-07-2024
- CRMD 10-30-2024
- Dividend Yield
- LAC N/A
- CRMD N/A
- EPS Growth
- LAC N/A
- CRMD N/A
- EPS
- LAC N/A
- CRMD N/A
- Revenue
- LAC N/A
- CRMD $12,262,234.00
- Revenue This Year
- LAC N/A
- CRMD N/A
- Revenue Next Year
- LAC N/A
- CRMD $277.75
- P/E Ratio
- LAC N/A
- CRMD N/A
- Revenue Growth
- LAC N/A
- CRMD 41184.20
- 52 Week Low
- LAC $2.02
- CRMD $2.89
- 52 Week High
- LAC $7.71
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- LAC 42.95
- CRMD 39.75
- Support Level
- LAC $3.08
- CRMD $8.23
- Resistance Level
- LAC $3.29
- CRMD $9.02
- Average True Range (ATR)
- LAC 0.17
- CRMD 0.47
- MACD
- LAC -0.01
- CRMD -0.01
- Stochastic Oscillator
- LAC 37.86
- CRMD 26.60
About LAC Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.